Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes

Annals of the New York Academy of Sciences

Volumn 958, Issue , 2002, Pages 77-88

  Sharif, Shayan ^a   Arreaza, Guillermo A ^a   Zucker, Peter ^a   Delovitch, Terry L ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Alpha galactosylceramide; Islet transplantation; NKT; NOD; Type I diabetes

Indexed keywords

CYCLOPHOSPHAMIDE; GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

AUTOIMMUNE DISEASE; CONFERENCE PAPER; CYTOKINE RELEASE; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; NATURAL KILLER CELL; NONHUMAN; TH1 CELL; TH2 CELL;

EID: 0036268008     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02949.x     Document Type: Conference Paper

References (54)

1. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
2. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
3. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
4. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism
5. Mouse CD1-specific NK1 T cells: Development, specificity, and function
6. Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells
7. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain
8. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells
9. NKT cells are phenotypically and functionally diverse
10. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
11. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
12. NKT cells: Facts, functions and fallacies
13. Selection of phenotypically distinct NK1.1+ T cells upon antigen expression in the thymus or in the liver
14. Development of Valpha4+ NK T cells in the early stages of embryogenesis
15. CD1d-glycolipid tetramers: A new tool to monitor natural killer T cells in health and disease
16. Natural ligand of mouse CD1d1: Cellular glycosylphosphatidylinositol
17. Cutting edge: The IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: Exploring the role of GPIs in NK T cell activation and antimalarial responses
18. CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides
19. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
20. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
21. Activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
22. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4.
23. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice
24. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease
25. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
26. Immunological characteristics of intragraft NKR-P1+ TCR alpha beta+ T (NKT) cells in rat hepatic allografts
27. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance
28. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance
29. MIP-2 recruits NKT cells to the spleen during tolerance induction
30. Regulation of experimental autoimmune encephalomyelitis in the C57BL/6J Mouse by NK1.1(+), DX5(+), alphabeta(+) T cells
31. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells
32. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice
33. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis
34. Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA)
35. Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy
36. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes
37. Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes
38. +-like thymocytes in the NOD mouse
39. Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice
40. Diabetes prone BB rats are severely deficient in natural killer T cells
41. IL-7 reverses NK1+ T cell-defective IL-4 production in the non-obese diabetic mouse
42. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
43. Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes
44. NK T Cell-induced protection against diabetes in Valpha14-Jalpha281 transgenic nonobese diabetic mice is associated with a Th2 shift circum-scribed regionally to the islets and functionally to islet autoantigen
45. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus
46. Activation of NKT cells by alpha galactosylceramide treatment prevents the onset and recurrence of autoimmune type I diabetes
47. Prevention of autoimmune diabetes in NOD mice by the natural killer T cell ligand α-galactosylceramide
48. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes
49. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets
50. Importance of donor-derived lymphocytes in the protection of pancreaticoduodenal or islet grafts from recurrent autoimmunity: A role for RT6+NKR-P1+ T cells
51. CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice
52. Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of syngeneic pancreatic islet grafts in nonobese diabetic mice: Islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts
53. Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Va24+Vβ11+ T cells
54. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution